Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 26, Issue 7; July 1, 2006

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

Vasoocclusion in Sickle Cell Anemia: Are Platelets Really Involved?

Joel S. Bennett
Arterioscler Thromb Vasc Biol. 2006;26:1415-1416, doi:10.1161/01.ATV.0000227595.97898.3f.
Full Text | PDF  

Beneficial Effects of Neuronal Nitric Oxide Synthase in Atherosclerosis

Charles J. Lowenstein
Arterioscler Thromb Vasc Biol. 2006;26:1417-1418, doi:10.1161/01.ATV.0000226550.89264.91.
Full Text | PDF  

New Tricks From an Old Dog: Nitric Oxide-Independent Effects of Dimethylarginine Dimethylaminohydrolase

James Leiper and Patrick Vallance
Arterioscler Thromb Vasc Biol. 2006;26:1419-1420, doi:10.1161/01.ATV.0000229598.55602.17.
Full Text | PDF  

Inflammation and Atherosclerosis: Group IIa and Group V sPLA2 Are Not Redundant

Frederick C. de Beer and Nancy R. Webb
Arterioscler Thromb Vasc Biol. 2006;26:1421-1422, doi:10.1161/01.ATV.0000227561.89488.9a.
Full Text | PDF  

 

Brief ReviewsBack

Jian-Su Shao, Jun Cai, and Dwight A. Towler
Arterioscler Thromb Vasc Biol. 2006;26:1423-1430; published online before print April 6 2006, doi:10.1161/01.ATV.0000220441.42041.20.
Abstract | Full Text | PDF
Vascular calcification increasingly afflicts our aging and dysmetabolic population. Once considered a passive process, it has emerged as an actively regulated form of calcified tissue metabolism, resembling the mineralization of endochondral and membranous bone. In this review, we discuss the biology of vascular calcification. We highlight how aortic fibrofatty tissue expansion (adventitia, valve interstitium), the adventitial-medial vasa, vascular matrix, and matrix vesicle metabolism contribute to the regulation of aortic calcium deposition, with greatest emphasis placed on diabetic vascular disease.  

Stefan Liebner, Ugo Cavallaro, and Elisabetta Dejana
Arterioscler Thromb Vasc Biol. 2006;26:1431-1438; published online before print March 23 2006, doi:10.1161/01.ATV.0000218510.04541.5e.
Abstract | Full Text | PDF
Excess NO causes apoptosis through the ER stress pathway in some types of cells. It was found that the ER stress pathway is activated by various stresses, and when stresses are severe, apoptosis is induced. The NO-induced ER stress pathway may be involved in pathogenesis of various vascular diseases.  

Tomomi Gotoh and Masataka Mori
Arterioscler Thromb Vasc Biol. 2006;26:1439-1446; published online before print April 27 2006, doi:10.1161/01.ATV.0000223900.67024.15.
Abstract | Full Text | PDF
Excess NO causes apoptosis through the ER stress pathway in some types of cells. It was found that the ER stress pathway is activated by various stresses, and when stresses are severe, apoptosis is induced. The NO-induced ER stress pathway may be involved in pathogenesis of various vascular diseases.  

Mitsuaki Isobe, Hisanori Kosuge, and Jun-ichi Suzuki
Arterioscler Thromb Vasc Biol. 2006;26:1447-1456; published online before print April 20 2006, doi:10.1161/01.ATV.0000222906.78307.7b.
Abstract | Full Text | PDF
Cardiac allograft vasculopathy (CAV) is a serious complication after heart transplantation. Continuous minor endothelial cell damage and subsequent T cell activation evoke inflammatory processes. Many costimulatory pathways for T cell activation are involved. The role of these pathways in CAV development and atherogenesis are discussed in this brief review.  

 

Vascular BiologyBack

Henrik Lindskog, Elisabet Athley, Erik Larsson, Samuel Lundin, Mats Hellström, and Per Lindahl
Arterioscler Thromb Vasc Biol. 2006;26:1457-1464; published online before print April 20 2006, doi:10.1161/01.ATV.0000222925.49817.17.
Abstract | Full Text | PDF | Data Supplement
We developed an ES cell-based angiogenesis/vasculogenesis model and characterized the system for VSMC and pericyte differentiation. Five days of culture on OP9 feeder cells induced expression of VSMC/pericyte-specific genes in mouse ES cells. The induction was temporally separated from the induction of SMC-specific genes, which suggest regulation by separate mechanisms. Finally, PDGFB and TGFß1 were dispensable for pericyte differentiation.  

Koichi Kobayashi, Takahisa Kondo, Natsuo Inoue, Mika Aoki, Masaaki Mizuno, Kimihiro Komori, Jun Yoshida, and Toyoaki Murohara
Arterioscler Thromb Vasc Biol. 2006;26:1465-1472; published online before print April 27 2006, doi:10.1161/01.ATV.0000223865.64812.26.
Abstract | Full Text | PDF | Data Supplement
Ang-1 gene and BM-MNCs combination therapy significantly augmented the angiographic score and capillary density, accompanied by functional improvement of skin ulcer score and TcO2 in the ischemic limb. This new Ang-1 gene and BM-MNC combination therapy enhances not only quantitative but also qualitative angiogenesis in ischemic tissues.  

Cam Patterson, Sabeen Mapera, Hui-Hua Li, Nageswara Madamanchi, Eleanor Hilliard, Rob Lineberger, Robert Herrmann, and Peter Charles
Arterioscler Thromb Vasc Biol. 2006;26:1473-1480; published online before print April 27 2006, doi:10.1161/01.ATV.0000223866.42883.3b.
Abstract | Full Text | PDF | Data Supplement
We used smooth muscle cells to compare the activities of rapamycin and paclitaxel. Rapamycin potently activates AKT-dependent signaling, an effect that causes phosphorylation of FOXO1. This effect is associated with attenuation of the anti-migratory effects of rapamycin and with protection against cytotoxicity, both of which are dependent on FOXO1 phosphorylation.  

Jun-Yang Liou, Sang Lee, Dipak Ghelani, Nevenka Matijevic-Aleksic, and Kenneth K. Wu
Arterioscler Thromb Vasc Biol. 2006;26:1481-1487; published online before print April 27 2006, doi:10.1161/01.ATV.0000223875.14120.93.
Abstract | Full Text | PDF | Data Supplement
We postulated that EC-synthesized PGI2 protects ECs from apoptosis. Results show that PGI2 generated by transduction with an adenoviral vector containing a bicistronic cyclooxygenase-1 and PGI2 synthase construct (Ad-COPI) or synthetic carbaprostacyclin (cPGI2) suppressed H2O2-induced EC apoptosis by a novel PPAR{delta}-mediated 14-3-3{alpha} transcriptional upregulation.  

Kazuhiro Hasegawa, Shu Wakino, Toru Tanaka, Masumi Kimoto, Satoru Tatematsu, Takeshi Kanda, Kyoko Yoshioka, Koichiro Homma, Naoki Sugano, Masahiko Kurabayashi, Takao Saruta, and Koichi Hayashi
Arterioscler Thromb Vasc Biol. 2006;26:1488-1494; published online before print March 30 2006, doi:10.1161/01.ATV.0000219615.88323.b4.
Abstract | Full Text | PDF | Data Supplement
This study demonstrates PKA- and Sp1-dependent transcriptional upregulation of VEGF by DDAH2 in vascular endothelial cells. This mechanism is specific for DDAH2 and independent of NO/NOS system. The induction of VEGF by DDAH2 may contribute to DDAH-induced angiogenesis and constitute a novel therapeutic target of angiogenesis-related diseases.  

Ralf Köhler, Willm-Thomas Heyken, Philipp Heinau, Rudolf Schubert, Han Si, Michael Kacik, Christoph Busch, Ivica Grgic, Tanja Maier, and Joachim Hoyer
Arterioscler Thromb Vasc Biol. 2006;26:1495-1502; published online before print May 4 2006, doi:10.1161/01.ATV.0000225698.36212.6a.
Abstract | Full Text | PDF | Data Supplement
Ca2+-permeable mechanosensitive channels are believed to be important in endothelial mechanotransduction. The present study provides evidence that the TRPV4 channel, a putatively mechanosensitive member of the TRPV family, mediates wall shear stress-induced vasodilatation in a NO-dependent manner.  

Mingyi Wang, Di Zhao, Gaia Spinetti, Jing Zhang, Li-Qun Jiang, Gianfranco Pintus, Robert Monticone, and Edward G. Lakatta
Arterioscler Thromb Vasc Biol. 2006;26:1503-1509; published online before print May 11 2006, doi:10.1161/01.ATV.0000225777.58488.f2.
Abstract | Full Text | PDF | Data Supplement
We analyzed MMP-2 effects on TGF-ß1 activation status and downstream signaling during age-associated arterial remodeling. MMP-2 increased TGF-ß1 activity, collagen, and fibronectin within aortic rings or VSMCs from young rats to the levels that occur in old animals. All of these effects are substantially reduced by inhibition of MMP-2.  

Xiao Qin, Matthew A. Corriere, Lynn M. Matrisian, and Raul J. Guzman
Arterioscler Thromb Vasc Biol. 2006;26:1510-1516; published online before print May 11 2006, doi:10.1161/01.ATV.0000225807.76419.a7.
Abstract | Full Text | PDF | Data Supplement
Arterial calcification is associated with MMP-mediated matrix degradation. Inhibiting MMP activity with doxycycline or the synthetic MMP-inhibitor GM6001 prevents calcium accumulation in the arterial wall.  

John W. Elrod, James J.M. Greer, Nathan S. Bryan, Will Langston, Jeffrey F. Szot, Henock Gebregzlabher, Stefan Janssens, Martin Feelisch, and David J. Lefer
Arterioscler Thromb Vasc Biol. 2006;26:1517-1523; published online before print April 27 2006, doi:10.1161/01.ATV.0000224324.52466.e6.
Abstract | Full Text | PDF | Data Supplement
Cardiomyoctye-specific eNOS overexpression (CS eNOS-Tg) versus systemic overexpression (SYS eNOS-Tg) was evaluated in MI-R injury. CS eNOS-Tg mice displayed decreased infarct size and preservation of cardiac function compared with SYS eNOS-Tg mice. These results provide evidence that site-specific targeting of eNOS gene therapy may be more advantageous in limiting MI-R injury.  

Fawzi A. Babiker, Daniel Lips, Rainer Meyer, Els Delvaux, Pieter Zandberg, Ben Janssen, Guillaume van Eys, Christian Grohé, and Pieter A. Doevendans
Arterioscler Thromb Vasc Biol. 2006;26:1524-1530; published online before print April 20 2006, doi:10.1161/01.ATV.0000223344.11128.23.
Abstract | Full Text | PDF | Data Supplement
E2 protects the murine heart against LVH via ERß. Presence of E2 antagonizes the increase in heart weight with TAC. This protective effect is played by blocking the increased phosphorylation of p38-MAPK and increasing the expression of ANF. ER{alpha} appears to be involved in regulation of other processes.  

Haixiang Yu, Karen Sliedregt-Bol, Herman Overkleeft, Gijs A. van der Marel, Theo J.C. van Berkel, and Erik A.L. Biessen
Arterioscler Thromb Vasc Biol. 2006;26:1531-1537; published online before print May 4 2006, doi:10.1161/01.ATV.0000225286.30710.af.
Abstract | Full Text | PDF | Data Supplement
Synthetic peptide inhibitor of NFAT selectively and potently inhibits NFAT activation and vSMC proliferation. NFAT and MEK-ERK pathways act in concert to trigger vSMC proliferation. NFAT is the key regulator essential for PDGF-BB-induced vSMC proliferation. VIVIT peptide may lead to more selective and less toxic approaches in antirestenosis therapy.  

 

Atherosclerosis and LipoproteinsBack

Gregory T. Jones, I. Patrick Kay, J.W. S. Chu, G.T. Wilkins, L.V. Phillips, M. McCormick, A.M. van Rij, and M.J.A. Williams
Arterioscler Thromb Vasc Biol. 2006;26:e121-e125; published online before print May 11 2006, doi:10.1161/01.ATV.0000226544.93089.7f.
Abstract | Full Text | PDF
This study aimed to determine whether plasma MMP-9 or TIMP-1 levels were elevated in patients with a history of (bare metal) in-stent restenosis. Plasma active MMP-9 was independently associated with ISR with a stratified risk association with the number of sites of ISR. Future studies should therefore prospectively evaluate plasma levels of active MMP-9 as a possible independent predictor of ISR.  

Gregory T. Jones, I. Patrick Kay, J.W.S. Chu, G.T. Wilkins, L.V. Phillips, M. McCormick, A.M. van Rij, and M.J.A. Williams
Arterioscler Thromb Vasc Biol. 2006;26:1538.
Abstract | PDF  

Peter J. Kuhlencordt, Stefanie Hötten, Johannes Schödel, Sebastian Rützel, Kai Hu, Julian Widder, Alexander Marx, Paul L. Huang, and Georg Ertl
Arterioscler Thromb Vasc Biol. 2006;26:1539-1544; published online before print April 20 2006, doi:10.1161/01.ATV.0000223143.88128.19.
Abstract | Full Text | PDF | Data Supplement
Here we test whether neuronal NOS (nNOS) deficiency affects atherosclerosis in apoE/nNOS{alpha} double knockout (DKO) and apoE knockout animals. Male and female DKO animals showed a significant increase in lesion-area. Thus, nNOS{alpha} protects against atherosclerosis. Female but not male DKO mice showed a significant reduction in mean arterial blood pressure.  

Bharti Mackness, Rozenn Quarck, Wim Verreth, Mike Mackness, and Paul Holvoet
Arterioscler Thromb Vasc Biol. 2006;26:1545-1550; published online before print April 20 2006, doi:10.1161/01.ATV.0000222924.62641.aa.
Abstract | Full Text | PDF
We used adenovirus-mediated PON1 gene transfer to overexpress human PON1 in mice with combined leptin and LDL receptor deficiency, a model of metabolic syndrome. Overexpressing PON1 in this mouse model of metabolic syndrome inhibited the development of atherosclerosis, probably by reducing oxidized LDL in the plaque and plasma, thereby preventing its proatherogenic effects.  

Kristina Edfeldt, Birgitta Agerberth, Martin E. Rottenberg, Gudmundur H. Gudmundsson, Xiong-Biao Wang, Kaushik Mandal, Qingbo Xu, and Zhong-qun Yan
Arterioscler Thromb Vasc Biol. 2006;26:1551-1557; published online before print April 27 2006, doi:10.1161/01.ATV.0000223901.08459.57.
Abstract | Full Text | PDF
To understand the function of vascular innate immunity in atherosclerosis, we investigated the role of the antimicrobial cathelicidin peptide LL-37 in atherosclerosis. We found that LL-37 is produced in atherosclerotic lesions, where it may function as an immune modulator by activating adhesion molecule and chemokine expression, thus enhancing innate immunity in atherosclerosis.  

Paul Holvoet, Penelope C. Davey, Dieuwke De Keyzer, Mory Doukouré, Els Deridder, Marie-Luce Bochaton-Piallat, Giulio Gabbiani, Emmanuel Beaufort, Karine Bishay, Nancy Andrieux, Nora Benhabilès, and Gérard Marguerie
Arterioscler Thromb Vasc Biol. 2006;26:1558-1565; published online before print May 11 2006, doi:10.1161/01.ATV.0000226553.01555.02.
Abstract | Full Text | PDF | Data Supplement
We searched for genes of which their expression in macrophages correlates with the complexity and oxidized LDL content of plaques in coronary arteries of hypercholesterolemic swine. Among 1653 deregulated genes, the interferon regulatory factor 1 (IRF1; R2=0.69) and toll-like receptor 2 (TLR2; R2=0.18) were the strongest positive gene correlates of both complexity and oxidized LDL content. Superoxide dismutase 1 (SOD1; R2=0.57) was the strongest inverse correlate of oxLDL. IRF1 and TLR2 protein correlated positively, and SOD1 protein correlated negatively with plaque oxLDL. OxLDL-induced THP-1 foam cell generation was associated with increased IRF1 and TLR2 and decreased SOD1 expression.  

Björn Magnusson, Lennart Asp, Pontus Boström, Michel Ruiz, Pia Stillemark-Billton, Daniel Lindén, Jan Borén, and Sven-Olof Olofsson
Arterioscler Thromb Vasc Biol. 2006;26:1566-1571; published online before print April 20 2006, doi:10.1161/01.ATV.0000223345.11820.da.
Abstract | Full Text | PDF | Data Supplement
An increase in the amount of ADRP sequestered fatty acids in triglycerides in cytosolic lipid droplets and prevented them from being incorporated into triglycerides of VLDL. A knockdown (siRNA) decreased the pool of cytosolic lipid droplets and promoted the ß-oxidation of the stored fatty acids and the secretion of apoB-48 VLDL1.  

David T. Valenta, Nicolas Ogier, Gary Bradshaw, Audrey S. Black, David J. Bonnet, Laurent Lagrost, Linda K. Curtiss, and Catherine M. Desrumaux
Arterioscler Thromb Vasc Biol. 2006;26:1572-1578; published online before print May 4 2006, doi:10.1161/01.ATV.0000225700.43836.ae.
Abstract | Full Text | PDF | Data Supplement
Using bone marrow transplantation, macrophage-derived PLTP was shown to be atheroprotective in hypercholesterolemic mice fed a high-fat diet. This effect was only observed in mice with normal apoAI plasma levels and not in transgenic mice with elevated human apoAI plasma levels.  

Birgitta Rosengren, Helena Peilot, Mia Umaerus, Ann-Cathrine Jönsson-Rylander, Lillemor Mattsson-Hultén, Carina Hallberg, Philippe Cronet, Mariam Rodriguez-Lee, and Eva Hurt-Camejo
Arterioscler Thromb Vasc Biol. 2006;26:1579-1585; published online before print April 6 2006, doi:10.1161/01.ATV.0000221231.56617.67.
Abstract | Full Text | PDF | Data Supplement
SPLA2-V was observed in human and mouse lesions associated with smooth muscle cells and surrounding foam cells in lipid cores. Proteoglycans increased the activity of sPLA2-V toward low-density lipoproteins. Western diet induced sPLA2-V expression in mouse aorta but not that of sPLA2-IIA. These enzymes may contribute to atherosclerosis by different pathways.  

Wolfgang Koenig, Dorothee Twardella, Hermann Brenner, and Dietrich Rothenbacher
Arterioscler Thromb Vasc Biol. 2006;26:1586-1593; published online before print April 20 2006, doi:10.1161/01.ATV.0000222983.73369.c8.
Abstract | Full Text | PDF
We found that lipoprotein-associated phospholipase A2 (Lp-PLA2) strongly predicts secondary cardiovascular events in patients with manifest coronary heart disease (CHD). In multivariable analysis, even including markers of inflammation, renal function, and hemodynamic stress, patients in the top tertile of the Lp-PLA2 mass and activity distribution showed -fold increased risk compared with those in the bottom tertile.  

George O. Angheloiu, Joseph T. Arendt, Markus G. Müller, Abigail S. Haka, Irene Georgakoudi, Jason T. Motz, Obrad R. Scepanovic, Barry D. Kuban, Jonathan Myles, Frank Miller, Eugene A. Podrez, Maryann Fitzmaurice, John R. Kramer, and Michael S. Feld
Arterioscler Thromb Vasc Biol. 2006;26:1594-1600; published online before print May 4 2006, doi:10.1161/01.ATV.0000225699.36212.23.
Abstract | Full Text | PDF | Data Supplement
We demonstrate that intrinsic fluorescence and diffuse reflectance accurately detect coronary plaques with superficial foam cells associated with proteoglycans and smooth muscle cells, 2 markers of coronary erosion. This is a step in our program to develop spectroscopic techniques for real-time in vivo diagnosis of vulnerable atherosclerotic plaque.  

Rikin A. Trivedi, Chinthake Mallawarachi, Jean-Marie U-King-Im, Martin J. Graves, Jo Horsley, Martin J. Goddard, Andrew Brown, Liqun Wang, Peter J. Kirkpatrick, John Brown, and Jonathan H. Gillard
Arterioscler Thromb Vasc Biol. 2006;26:1601-1606; published online before print April 20 2006, doi:10.1161/01.ATV.0000222920.59760.df.
Abstract | Full Text | PDF
The in vivo detection of plaque inflammation was evaluated using a macrophage labeling MRI contrast agent. Areas of focal signal loss on MRI corresponded to macrophage populations, thereby identifying inflamed plaques in 24 of 27 symptomatic individuals with severe ICA stenosis were detected and confirmed histologically.  

Romana Femia, Andrea Natali, Antonio L’Abbate, and Ele Ferrannini
Arterioscler Thromb Vasc Biol. 2006;26:1607-1612; published online before print April 20 2006, doi:10.1161/01.ATV.0000222929.99098.1f.
Abstract | Full Text | PDF | Data Supplement
In 2141 consecutive patients undergoing quantitative coronary angiography for the clinical work-up of ischemia, moderate (<231g/wk in men, <154 g/wk in women) alcohol consumption was associated with less coronary atherosclerosis and a lower risk (HR, 0.84; 95% CI, 0.71 to 1.00) of cardiac death at follow-up independently of classical cardiovascular risk factors.  

Dov Shiffman, Charles M. Rowland, Judy Z. Louie, May M. Luke, Lance A. Bare, Joel I. Bolonick, Bradford A. Young, Joseph J. Catanese, Charles F. Stiggins, Clive R. Pullinger, Eric J. Topol, Mary J. Malloy, John P. Kane, Stephen G. Ellis, and James J. Devlin
Arterioscler Thromb Vasc Biol. 2006;26:1613-1618; published online before print May 11 2006, doi:10.1161/01.ATV.0000226543.77214.e4.
Abstract | Full Text | PDF | Data Supplement
Genetic associations with early-onset myocardial infarction were identified by testing successively fewer SNPs in 3 consecutive case-control studies. Thus, 11 647 SNPs were tested in the first study, 666 in the second study, and only 8 SNPs were tested in the third study.  

Michel Marcil, Hai Vu, Wei Cui, Zari Dastani, James C. Engert, Daniel Gaudet, Manuel Castro-Cabezas, Allan D. Sniderman, Jacques Genest, Jr, and Katherine Cianflone
Arterioscler Thromb Vasc Biol. 2006;26:1619-1625; published online before print April 20 2006, doi:10.1161/01.ATV.0000222907.72985.0b.
Abstract | Full Text | PDF | Data Supplement
DNA sequencing of C5L2-ASP receptor identified a heterozygous Ser323->Ile substitution in the carboxyl-terminal region. Eight heterozygous family members demonstrated increased plasma triglyceride, cholesterol, LDL, apolipoprotein B and ASP. C5L2(+/-) cells had reduced ASP response and Bmax. S323I may alter C5L2 function and contribute to familial combined hyperlipidemia.  

 

ThrombosisBack

Sheritha P. Lee, Kenneth I. Ataga, Eugene P. Orringer, David R. Phillips, and Leslie V. Parise
Arterioscler Thromb Vasc Biol. 2006;26:1626-1631; published online before print April 6 2006, doi:10.1161/01.ATV.0000220374.00602.a2.
Abstract | Full Text | PDF
CD40L is elevated in plasma but depleted from platelets in sickle cell anemia (SCA). These differences are exaggerated during painful crises. CD40L is implicated in SCA plasma-induced production of tissue factor, ICAM-1, and B cells, suggesting that platelet-derived CD40L contributes to inflammation and coagulation in SCA.  

Martin Rücker, Thilo Schäfer, Claudia Scheuer, Yves Harder, Brigitte Vollmar, and Michael D. Menger
Arterioscler Thromb Vasc Biol. 2006;26:1632-1639; published online before print April 20 2006, doi:10.1161/01.ATV.0000223144.65958.c3.
Abstract | Full Text | PDF
Using a rat thromboembolization model and intravital fluorescence microscopy, this study demonstrates that heat shock priming induces endothelium-derived plasminogen activator expression in vivo, and accelerates spontaneous recanalization of thromboembolized microvasculature. This was completely blunted by application of plasminogen activator inhibitor-1. Thus, heat shock induces endogenous hyperfibrinolysis, which promotes recanalization of thromboembolized microvasculature.  

Valerie Schulte, H. Peter Reusch, Miroslava Pozgajová, David Varga-Szabó, Christian Gachet, and Bernhard Nieswandt
Arterioscler Thromb Vasc Biol. 2006;26:1640-1647; published online before print May 4 2006, doi:10.1161/01.ATV.0000225697.98093.ed.
Abstract | Full Text | PDF
Collagen and thrombin are major platelet agonists. The collagen receptor GPVI is an attractive antithrombotic target because its inhibition/absence results in profound antithrombotic protection but no bleeding in mice. We show that mice treated with the anti-GPVI antibody JAQ1 transiently display reduced platelet responses to thrombin and protection against lethal tissue factor-induced thromboembolism.  

Thomas Heitzer, Volker Rudolph, Edzard Schwedhelm, Manuela Karstens, Karsten Sydow, Michelle Ortak, Peter Tschentscher, Thomas Meinertz, Rainer Böger, and Stephan Baldus
Arterioscler Thromb Vasc Biol. 2006;26:1648-1652; published online before print May 4 2006, doi:10.1161/01.ATV.0000225288.74170.dc.
Abstract | Full Text | PDF
Platelet adenosine phosphate receptor blockade by clopidogrel improved endothelium-dependent vasodilation to acetylcholine and vascular bioavailability of nitric oxide in the human forearm of patients with symptomatic coronary artery disease. In addition, inflammatory parameters, ie, hsCRP, sCD40L, and RANTES and oxidative parameters, ie, 8-iso-PG F2{alpha} were reduced. These findings support the concept that activated platelets contribute to endothelial dysfunction and impaired nitric oxide bioavailability.  

H.C. de Boer, C. Verseyden, L.H. Ulfman, J.J. Zwaginga, I. Bot, E.A. Biessen, T.J. Rabelink, and A.J. van Zonneveld
Arterioscler Thromb Vasc Biol. 2006;26:1653-1659; published online before print April 20 2006, doi:10.1161/01.ATV.0000222982.55731.f1.
Abstract | Full Text | PDF | Data Supplement
The hemostatic factors fibrin and activated platelets cooperatively provide the local cues for CD34+ cells to escape (tether and roll) from flowing blood, migrate towards an injury, and differentiate into a more mature endothelial phenotype, ultimately leading to repair of a vascular injury.  

Majoie Hemelaar, Jan Rosing, Peter Kenemans, M. Christella L.G.D. Thomassen, Didi D.M. Braat, and Marius J. van der Mooren
Arterioscler Thromb Vasc Biol. 2006;26:1660-1666; published online before print April 27 2006, doi:10.1161/01.ATV.0000224325.96659.53.
Abstract | Full Text | PDF
This randomized, double-blind clinical trial in 90 healthy postmenopausal women compared the effects of intranasal E2/NET and oral E2/NETA therapy on nAPCsr and on other hemostatic parameters associated with venous thrombosis. Effects in the intranasal group were smaller than in the oral group, which may suggest a lower venous thrombosis risk.  

Anders Mälarstig, Bertil Lindahl, Lars Wallentin, and Agneta Siegbahn
Arterioscler Thromb Vasc Biol. 2006;26:1667-1673; published online before print April 20 2006, doi:10.1161/01.ATV.0000222908.78873.36.
Abstract | Full Text | PDF | Data Supplement
Elevation of soluble CD40L was associated with myocardial infarction in the FRISC-II trial, which enrolled 2457 patients with acute coronary syndromes. A prolonged dalteparin treatment was more beneficial in patients with elevated sCD40L. The -3459 A>G SNP in the CD40LG gene was identified as a novel regulator of sCD40L levels.  

Katsuyuki Miura, Hideaki Nakagawa, Hirotsugu Ueshima, Akira Okayama, Shigeyuki Saitoh, J. David Curb, Beatriz L. Rodriguez, Kiyomi Sakata, Nagako Okuda, Katsushi Yoshita, Jeremiah Stamler for the INTERMAP and INTERLIPID Research Groups
Arterioscler Thromb Vasc Biol. 2006;26:1674-1679; published online before print May 4 2006, doi:10.1161/01.ATV.0000225701.20965.b9.
Abstract | Full Text | PDF
We investigated whether dietary factors explain higher plasma fibrinogen levels in Japanese emigrants living a Western lifestyle in Hawaii compared with Japanese in Japan. Data from this epidemiologic study indicate that higher intakes of iron, sugar, and caffeine, plus obesity, account largely for higher fibrinogen levels with Westernized lifestyle.  

 

Letters to the EditorBack

Inhibition of Extracellular Signal–Regulated Kinase in Liver of Hyperhomocysteinemic Mice

Julien Hamelet, Karine Demuth, Jean-Maurice Delabar, and Nathalie Janel
Arterioscler Thromb Vasc Biol. 2006;26:e126-e127, doi:10.1161/01.ATV.0000225290.10643.ea.
Full Text | PDF  

Letter to the Editor: Modulation of Toll-Like Receptor Expression: A Further Effect of Statins?

José C. Alves-Filho and Fernando Q. Cunha
Arterioscler Thromb Vasc Biol. 2006;26:e128, doi:10.1161/01.ATV.0000223146.16466.af.
Full Text | PDF  

 

News From the American Heart AssociationBack

News From the American Heart Association


Arterioscler Thromb Vasc Biol. 2006;26:B1.
PDF  

 

Meetings CalendarBack

Meetings Calendar


Arterioscler Thromb Vasc Biol. 2006;26:B2-B4.
PDF  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage